These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
563 related items for PubMed ID: 11847474
1. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults. Kim HJ, Kwon SH, Kim SW, Park DJ, Shin CS, Park KS, Kim SY, Cho BY, Lee HK. Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474 [Abstract] [Full Text] [Related]
2. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG. J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159 [Abstract] [Full Text] [Related]
3. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3. Fukuda I, Hizuka N, Itoh E, Yasumoto K, Ishikawa Y, Murakami Y, Sata A, Takano K. Endocr J; 2002 Jun; 49(3):379-86. PubMed ID: 12201224 [Abstract] [Full Text] [Related]
8. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly. Pekic S, Doknic M, Miljic D, Joksimovic M, Glodic J, Djurovic M, Dieguez C, Casanueva F, Popovic V. Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012 [Abstract] [Full Text] [Related]
9. Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly. Chen HS, Lin HD. J Endocrinol Invest; 1999 Feb; 22(2):98-103. PubMed ID: 10195375 [Abstract] [Full Text] [Related]
14. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529 [Abstract] [Full Text] [Related]
15. Diagnostic utility of serum GH, IGF-1 and IGFBP3 in patients of acromegaly with uncontrolled diabetes: a pilot study. Dutta P, Singhal S, Sachdeva NK, Shah VN, Pathak A, Mukherjee KK, Bhansali A. J Assoc Physicians India; 2014 Aug; 62(8):686-90. PubMed ID: 25856936 [Abstract] [Full Text] [Related]
17. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients. Charalampaki P, Hildebrandt G, Schaeffer HJ, Schönau E, Klug N. Exp Clin Endocrinol Diabetes; 1998 Aug; 106(2):130-4. PubMed ID: 9628244 [Abstract] [Full Text] [Related]
18. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. Juul A, Skakkebaek NE. J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120 [Abstract] [Full Text] [Related]
19. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults. Thissen JP, Ketelslegers JM, Maiter D. Growth Regul; 1996 Dec; 6(4):222-9. PubMed ID: 8971551 [Abstract] [Full Text] [Related]
20. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children. Ali A, Hashim R, Khan FA, Sattar A, Ijaz A, Manzoor SM, Younas M. J Ayub Med Coll Abbottabad; 2009 Dec; 21(3):40-5. PubMed ID: 20929010 [Abstract] [Full Text] [Related] Page: [Next] [New Search]